BDBM350602 1-(4-bromophenyl)-3-[2,5- dioxo-4,4-di(propan-2- yl)imidazolidin-1-yl]urea::US10208071, Compound 64::US10434112, Compound 64::US10799518, Compound 64

SMILES CC(C)C1(NC(=O)N(NC(=O)Nc2ccc(Br)cc2)C1=O)C(C)C

InChI Key InChIKey=GMHUILWFSUMZOU-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350602   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350602(1-(4-bromophenyl)-3-[2,5- dioxo-4,4-di(propan-2- y...)
Affinity DataEC50:  3.80nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350602(1-(4-bromophenyl)-3-[2,5- dioxo-4,4-di(propan-2- y...)
Affinity DataEC50:  3.80nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350602(1-(4-bromophenyl)-3-[2,5- dioxo-4,4-di(propan-2- y...)
Affinity DataEC50:  3.80E+3nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent